4.6 Article

Relative Importance and Additive Effects of Maternal and Infant Risk Factors on Childhood Asthma

期刊

PLOS ONE
卷 11, 期 3, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0151705

关键词

-

资金

  1. Agency for Healthcare Research and Quality [R01 HS018454]
  2. NIH [K24 AI 077930]

向作者/读者索取更多资源

Background Environmental exposures that occur in utero and during early life may contribute to the development of childhood asthma through alteration of the human microbiome. The objectives of this study were to estimate the cumulative effect and relative importance of environmental exposures on the risk of childhood asthma. Methods We conducted a population-based birth cohort study of mother-child dyads who were born between 1995 and 2003 and were continuously enrolled in the PRIMA (Prevention of RSV: Impact on Morbidity and Asthma) cohort. The individual and cumulative impact of maternal urinary tract infections (UTI) during pregnancy, maternal colonization with group B streptococcus (GBS), mode of delivery, infant antibiotic use, and older siblings at home, on the risk of childhood asthma were estimated using logistic regression. Dose-response effect on childhood asthma risk was assessed for continuous risk factors: number of maternal UTIs during pregnancy, courses of infant antibiotics, and number of older siblings at home. We further assessed and compared the relative importance of these exposures on the asthma risk. In a subgroup of children for whom maternal antibiotic use during pregnancy information was available, the effect of maternal antibiotic use on the risk of childhood asthma was estimated. Results Among 136,098 singleton birth infants, 13.29% developed asthma. In both univariate and adjusted analyses, maternal UTI during pregnancy (odds ratio [OR] 1.2, 95% confidence interval [CI] 1.18, 1.25; adjusted OR [AOR] 1.04, 95% CI 1.02, 1.07 for every additional UTI) and infant antibiotic use (OR 1.21, 95% CI 1.20, 1.22; AOR 1.16, 95% CI 1.15, 1.17 for every additional course) were associated with an increased risk of childhood asthma, while having older siblings at home (OR 0.92, 95% CI 0.91, 0.93; AOR 0.85, 95% CI 0.84, 0.87 for each additional sibling) was associated with a decreased risk of childhood asthma, in a dose-dependent manner. Compared with vaginal delivery, C-section delivery increased odds of childhood asthma by 34% (OR 1.34, 95% CI 1.29, 1.39) in the univariate analysis and 11% after adjusting for other environmental exposures and covariates (AOR 1.11, 95% CI 1.06, 1.15). Maternal GBS was associated with a significant increased risk of childhood asthma in the univariate analysis (OR 1.27, 95% CI 1.19, 1.35), but not in the adjusted analysis (AOR 1.03, 95% CI 0.96, 1.10). In the subgroup analysis of children whose maternal antibiotic use information was available, maternal antibiotic use was associated with an increased risk of childhood asthma in a similar dose-dependent manner in the univariate and adjusted analyses (OR 1.13, 95% CI 1.12, 1.15; AOR 1.06, 95% CI 1.05, 1.08 for every additional course). Compared with infants with the lowest number of exposures (no UTI during pregnancy, vaginal delivery, at least five older siblings at home, no antibiotics during infancy), infants with the highest number of exposures (at least three UTIs during pregnancy, C-section delivery, no older siblings, eight or more courses of antibiotics during infancy) had a 7.77 fold increased odds of developing asthma (AOR: 7.77, 95% CI: 6.25, 9.65). Lastly, infant antibiotic use had the greatest impact on asthma risk compared with maternal UTI during pregnancy, mode of delivery and having older siblings at home. Conclusion Early-life exposures, maternal UTI during pregnancy (maternal antibiotic use), mode of delivery, infant antibiotic use, and having older siblings at home, are associated with an increased risk of childhood asthma in a cumulative manner, and for those continuous variables, a dose-dependent relationship. Compared with in utero exposures, exposures occurring during infancy have a greater impact on the risk of developing childhood asthma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Allergy

Nasopharyngeal Haemophilus and local immune response during infant respiratory syncytial virus infection

Meghan H. Shilts, Christian Rosas-Salazar, Kedir N. Turi, Devi Rajan, Seesandra V. Rajagopala, Megan F. Patterson, Tebeb Gebretsadik, Larry J. Anderson, R. Stokes Peebles, Tina V. Hartert, Suman R. Das

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Critical Care Medicine

Mapping the 17q12-21.1 Locus for Variants Associated with Early-Onset Asthma in African Americans

Hongsheng Gui, Albert M. Levin, Donglei Hu, Patrick Sleiman, Shujie Xiao, Angel C. Y. Mak, Mao Yang, Andrea J. Barczak, Scott Huntsman, Celeste Eng, Samantha Hochstadt, Ellen Zhang, Kyle Whitehouse, Samantha Simons, Whitney Cabral, Sami Takriti, Goncalo Abecasis, Thomas W. Blackwell, Hyun Min Kang, Deborah A. Nickerson, Soren Germer, David E. Lanfear, Frank Gilliland, W. James Gauderman, Rajesh Kumar, David J. Erle, Fernando D. Martinez, Hakon Hakonarson, Esteban G. Burchard, L. Keoki Williams

Summary: This study identified a functional variant at the 17q12-21.1 locus associated with early-onset asthma in African American individuals. The lead signal, rs11078928, was found to be the top association for early-onset asthma after meta-analysis across cohorts. Additionally, a haplotype analysis suggested that the asthma association most closely with this variant.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Article Virology

Performance evaluation of antibody tests for detecting infant respiratory syncytial virus infection

Samadhan J. Jadhao, Binh Ha, Courtney McCracken, Tebeb Gebretsadik, Christian Rosas-Salazar, James Chappell, Suman Das, Tina Hartert, Larry J. Anderson

Summary: RSV infection plays a major role in respiratory tract diseases in infants and throughout life. The RSV antibody enzyme-linked immunoassay is sensitive for detecting infant infection, and the two G EIAs can indicate the group of an earlier primary infection.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Allergy

SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome

Christian Rosas-Salazar, Kyle S. Kimura, Meghan H. Shilts, Britton A. Strickland, Michael H. Freeman, Bronson C. Wessinger, Veerain Gupta, Hunter M. Brown, Seesandra V. Rajagopala, Justin H. Turner, Suman R. Das

Summary: This study found complex associations between SARS-CoV-2 infection and the URT microbiome in adults, with viral load potentially impacting bacterial abundance. Further research is needed to explore how these viral-bacterial interactions can affect the clinical progression of COVID-19.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Review Pediatrics

E-cigarette and vaping product use-associated lung injury in the pediatric population: A critical review of the current literature

Jacob A. Kaslow, Christian Rosas-Salazar, Paul E. Moore

Summary: The significant increase in the use of electronic nicotine delivery systems (ENDS) among adolescents has raised concerns about potential long-term impacts on users, especially young individuals. While there is a wealth of literature on vaping and EVALI in adults, research on pediatric patients is lacking, highlighting the need for further investigation in this area.

PEDIATRIC PULMONOLOGY (2021)

Review Gastroenterology & Hepatology

Association between Oral Microbiome and Esophageal Diseases: A State-of-the-Art Review

Rachel Bernard, Irtiqa Fazili, Seesandra V. Rajagopala, Suman R. Das, Girish Hiremath

Summary: Further research is necessary to uncover the mechanisms by which the oral microbiome impacts the development and progression of esophageal diseases, as well as to explore if changes in the oral microbiome can influence the natural course of different esophageal conditions.

DIGESTIVE DISEASES (2022)

Article Allergy

Upper respiratory tract bacterial-immune interactions during respiratory syncytial virus infection in infancy

Christian Rosas-Salazar, Zheng-Zheng Tang, Meghan H. Shilts, Kedir N. Turi, Qilin Hong, Derek A. Wiggins, Christian E. Lynch, Tebeb Gebretsadik, James D. Chappell, R. Stokes Peebles, Larry J. Anderson, Suman R. Das, Tina Hartert

Summary: The study found that the upper respiratory tract (URT) microbiome during RSV ARI in infancy is associated with the acute local immune response, disease severity, and number of wheezing episodes in the fourth year of life. The diversity of the URT microbiome is related to the course of RSV ARI, and there are complex interactions between the URT microbiome and the immune system.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Otorhinolaryngology

Pharmacokinetic-based failure of a detergent virucidal for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) nasal infections: A preclinical study and randomized controlled trial

Charles R. Esther, Kyle S. Kimura, Yu Mikami, Caitlin E. Edwards, Suman R. Das, Michael H. Freeman, Britton A. Strickland, Hunter M. Brown, Bronson C. Wessinger, Veerain C. Gupta, Kate Von Wahlde, Quanhu Sheng, Li Ching Huang, Daniel R. Bacon, Adam J. Kimple, Agathe S. Ceppe, Takafumi Kato, Raymond J. Pickles, Scott H. Randell, Ralph S. Baric, Justin H. Turner, Richard C. Boucher

Summary: This study assessed the efficacy of a detergent-based virucidal agent in SARS-CoV-2-infected subjects and found that it had no impact on viral load or symptom scores in the clinical trial. Complementary in vitro studies confirmed this lack of efficacy, indicating a failure in drug absorption.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2022)

Article Immunology

Severe COVID-19 Is Associated With an Altered Upper Respiratory Tract Microbiome

Meghan H. Shilts, Christian Rosas-Salazar, Britton A. Strickland, Kyle S. Kimura, Mohammad Asad, Esha Sehanobish, Michael H. Freeman, Bronson C. Wessinger, Veerain Gupta, Hunter M. Brown, Helen H. Boone, Viraj Patel, Mali Barbi, Danielle Bottalico, Meaghan O'Neill, Nadeem Akbar, Seesandra V. Rajagopala, Simon Mallal, Elizabeth Phillips, Justin H. Turner, Elina Jerschow, Suman R. Das

Summary: This study aims to investigate the association between COVID-19 severity and the upper respiratory tract microbiome. The study found that as the severity of COVID-19 increased, the bacterial load, bacterial richness, and within-group microbiome composition dissimilarity in the upper respiratory tract also increased, while the relative abundance of a specific amplicon sequence variant decreased.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Article Infectious Diseases

COVID-19 severity from Omicron and Delta SARS-CoV-2 variants

Jesse O. Wrenn, Suman B. Pakala, Grant Vestal, Meghan H. Shilts, Hunter M. Brown, Sara M. Bowen, Britton A. Strickland, Timothy Williams, Simon A. Mallal, Ian D. Jones, Jonathan E. Schmitz, Wesley H. Self, Suman R. Das

Summary: The clinical outcomes of infections caused by the Omicron variant were compared to those caused by the Delta variant. It was found that infections caused by the Omicron variant were less severe, with significantly lower morbidity and mortality rates, compared to those caused by the Delta variant.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2022)

Article Allergy

Exclusive breast-feeding, the early-life microbiome and immune response, and common childhood respiratory illnesses

Christian Rosas-Salazar, Meghan H. Shilts, Zheng-Zheng Tang, Qilin Hong, Kedir N. Turi, Brittney M. Snyder, Derek A. Wiggins, Christian E. Lynch, Tebeb Gebretsadik, R. Stokes Peebles, Larry J. Anderson, Suman R. Das, Tina V. Hartert

Summary: Exclusive breast-feeding has a protective causal role in reducing the risk of lower respiratory tract infections, asthma, and allergic rhinitis in childhood. This association may be mediated through its impact on the early-life upper respiratory tract and gut microbiome, as well as the immune response in infancy.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Review Oncology

It Takes Two to Tango: A Review of Oncogenic Virus and Host Microbiome Associated Inflammation in Head and Neck Cancer

Mallory G. McKeon, Jean-Nicolas Gallant, Young J. Kim, Suman R. Das

Summary: Certain viruses, such as human papillomavirus (HPV) and Epstein-Barr virus (EBV), are associated with the development of head and neck cancer. This study reviews the mechanisms by which these viruses cause cellular transformation and chronic inflammation, and examines the interplay between viruses, cellular transformation, inflammation, and the local host microbiome in head and neck cancer.

CANCERS (2022)

Article Cardiac & Cardiovascular Systems

Gut Microbiota and Coronary Plaque Characteristics

Akihiro Nakajima, Satoru Mitomo, Haruhito Yuki, Makoto Araki, Lena Marie Seegers, Iris McNulty, Hang Lee, David Kuter, Midori Ishibashi, Kazuna Kobayashi, Jouke Dijkstra, Hirokazu Onishi, Hiroto Yabushita, Satoshi Matsuoka, Hiroyoshi Kawamoto, Yusuke Watanabe, Kentaro Tanaka, Shengpu Chou, Toru Naganuma, Masaaki Okutsu, Satoko Tahara, Naoyuki Kurita, Shotaro Nakamura, Suman Das, Sunao Nakamura, Ik-Kyung Jang

Summary: This study identified gut bacteria associated with vulnerable coronary plaque and greater plaque burden, which were also associated with elevated inflammatory or prothrombotic biomarkers.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Article Virology

Evolutionary dynamics of respiratory syncytial virus in Buenos Aires: Viral diversity, migration, and subgroup replacement

Stephanie Goya, Maria Florencia Lucion, Meghan H. Shilts, Maria del Valle Juarez, Angela Gentile, Alicia S. Mistchenko, Mariana Viegas, Suman R. Das

Summary: Globally, the human respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections (LRTIs) in children. This study sequenced the complete genomes of RSV from pediatric patients in Buenos Aires and found that RSV-B was dominant from 2014 to 2016 before being abruptly replaced by RSV-A in 2017. The decrease in RSV genomic diversity observed in Buenos Aires in 2016 may have allowed the RSV-A predominance switch in 2017.

VIRUS EVOLUTION (2023)

暂无数据